You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Profile for Austria Patent: E481096


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Austria Patent: E481096

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Dec 5, 2029 Abbvie NAMZARIC donepezil hydrochloride; memantine hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Austria Patent ATE481096: Scope, Claims, and Patent Landscape Analysis

Last updated: February 20, 2026

What is the scope of Austria patent ATE481096?

Patent ATE481096 is filed in Austria, covering specific aspects of a pharmaceutical compound or formulation. The patent likely includes claims directed to the chemical composition, method of synthesis, and therapeutic application. The scope is defined primarily by the claims section, which delineates the boundaries of patent protection.

Key elements generally include:

  • Chemical Structure: The core molecule, including specific substituents, stereochemistry, or derivatives, is detailed in the claims.
  • Method of Use: Claims may specify methods of administering the compound for particular indications.
  • Formulation: Claims may cover pharmaceutical compositions containing the compound.
  • Synthesis: Claims could describe specific processes for preparing the compound.

The exact scope depends on the language and breadth of the claims section, which should be examined directly for precise boundaries.

How broad are the claims of patent ATE481096?

Claim Breadth:

  • The claims typically range from narrow (covering specific derivatives or processes) to broad (covering general chemical classes).
  • Broad claims may encompass multiple compounds or uses, while narrow claims focus on specific embodiments.

Claim Types:

  • Product Claims: Cover the compound itself with minimal structural limitations.
  • Use Claims: Cover therapeutic applications, including specific indications.
  • Method Claims: Cover preparation or administration methods.

Comparison with Similar Patents:

  • Similar patents tend to have narrower claims if they focus on specific derivatives.
  • Broader patents may be challenged for lack of novelty or inventive step if claims are overly general.

What does the patent landscape look like around Austria patent ATE481096?

Domestic and International Patent Filings

  • Priority and Family Members: The patent family likely includes applications filed internationally under the Patent Cooperation Treaty (PCT) or European Patent Convention (EPC). These extensions provide territorial rights in multiple jurisdictions.
  • Competitor Patents: Several patents related to similar chemical classes or therapeutic methods exist. Competing patents may focus on:

    • Derivatives with enhanced efficacy
    • Alternative synthesis routes
    • Specific formulations or delivery systems

Key Patent Trends

  • Focus on Chemical Modifications: Patents increasingly aim at modifying core structures to improve pharmacokinetics or reduce side effects.
  • Combination Therapies: Multiple patents cover combinations of the patented compound with other pharmaceuticals.
  • Method of Treatment Claims: Emphasis on methods for treating specific diseases, such as cancers or neurological disorders.

Patent Filing Strategies

  • Firms tend to file broader initial claims and then pursue narrower claims during prosecution.
  • Filing in multiple jurisdictions protects against regional competition and patent workarounds.

Potential Challenges and Oppositions

  • Lack of Novelty: Similar compounds or methods disclosed in prior art may threaten patent validity.
  • Obviousness: Claims may be challenged if the modifications are considered obvious to skilled practitioners.
  • Clarity and Support: Claims must be fully supported by the patent description; ambiguity may lead to invalidation.

Summary of Critical Patent Data

Aspect Details
Filing Date The exact date is not provided; typically, patents have a 20-year term from filing.
Patent Status Likely granted or pending; exact status requires checking the Austrian Patent Office (APO) database.
Patent Term Expiry Usually 20 years from the filing date, subject to annuities and maintenance fees.
Patent Term Adjustments Not common in Austria; extensions are generally limited.
Geographic Coverage Austria; potential family members in PCT or EPC filings.

Implications for R&D and Commercialization

  • The patent protects the core innovation within Austria; licensing or collaboration opportunities depend on the scope.
  • Narrow claims limit freedom to operate but offer defensibility.
  • Broad claims can block competitors but risk invalidation if challenged.

Key Takeaways

  • Patent ATE481096's scope hinges on the specificity of its claims, balancing breadth with validity.
  • The patent landscape includes similar patents focusing on derivatives, formulations, and methods of use.
  • International patent filings expand territorial rights but face similar challenges regarding novelty and inventive step.
  • Monitoring competitors’ patent applications is essential to assess freedom to operate.
  • Patent expiry timelines influence strategic planning for commercialization and lifecycle management.

FAQs

1. How can I determine the exact claims of patent ATE481096?
Access the Austrian Patent Office (APO) database or patent register to download the patent documentation, which includes full claims.

2. Are broad chemical structure claims patentable in Austria?
Claims covering broad classes of compounds can be granted if they meet novelty and inventive step criteria, but they are often vulnerable to prior art challenges.

3. What is the typical lifespan of a patent like ATE481096?
Approximately 20 years from the filing date, subject to fee payments and no patent term adjustments.

4. Can similar patents threaten ATE481096’s exclusivity?
Yes, patents claiming similar compounds or methods may create litigation or invalidation risks if they predate or overlap with ATE481096.

5. How does filing strategy influence patent strength?
Filing broad initial claims and narrowing during prosecution offers stronger territorial protection and defensibility.

References

[1] Austrian Patent Office. (2023). Patent search database. https://www.patentamt.at
[2] World Intellectual Property Organization. (2023). Patent Cooperation Treaty (PCT) applications. https://www.wipo.int/pct/en/
[3] European Patent Office. (2023). Espacenet patent database. https://worldwide.espacenet.com

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.